COVIRNA is a patient-centred Innovation Action aiming to generate a diagnostic tool to identify COVID-19 patients at risk of developing fatal cardiovascular complications.
A joined-up EU wide approach to protecting our population.
Keep in touch
Sign up to our mailing list to receive occasional emails as we publish key project materials and commission new strands of work.
Identifying those at most risk from COVID-19
The overall goal of the COVIRNA project is to generate a diagnostic test based on cardiovascular RNA biomarkers highly predictive of the clinical outcomes of COVID-19 patients and to enable its rapid market uptake with the aim to improve individualised surveillance, care and follow-up of these patients in the context of the current pandemic.Find out more about the project
How we will do it
Our work packages are evolving, but include consideration and development of:
Existing & past
The LIH, through the Cardiovascular Research Unit of the Department of Population Health (DoPH), led by Dr Yvan Devaux, will be the Coordinator of “COVIRNA”. The consortium of organisations delivering COVIRNA includes:
News & Events
The COVIRNA project was presented at the Back to a Healthy Future event
On 21 – 22 September, the Back to a Healthy Future event took place in Brussels. This technological showcase event brought together companies and organisations from many European countries willing to respond rapidly to urgent needs in the healthcare system. The particular focus was on solutions t…
Event report: COVIRNA session at the EHMA 2022 Annual Conference highlights the potential of innovative diagnostic tools
On Friday, 17 June, the COVIRNA project hosted a session at the EHMA 2022 Annual Conference titled ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’. The session looked at the impact and benefits of the adoption of no…
COVIRNA project to host a session at the EHMA 2022 Annual Conference
The COVIRNA project will be participating in the EHMA 2022 Annual Conference with the session ‘The potential of innovative diagnostic tools: personalised disease management for improved health outcomes in COVID-19 patients’, on Friday, 17 June at 11:15 AM CET. EHMA 2022 Annual Conference&nbs…